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ABSTRACT: We want to address the clinical issue of too sparse supply of allograft in total hip replacement and ambitions of
controlling the grain size distribution. Bioglass BAG-S53P4 was evaluated as a bone graft additive to chemically treated allografts
with controlled grain size distribution. Allografts were chemically cleaned (CG) and mixed with BAG-S53P4 additive (BG) for
comparison. All samples were compacted with a dropped weight apparatus and then underwent a uniaxial compression test. The
yield limit was determined by a uniaxial compression test and density was recorded while flowability was calculated. There was no
difference between the yield stress limit of BG and CG after compaction (p¼0.432). Adding BAG-S53P4 reduced flowability and could
indicate better interlocking mechanism between particles. Adding BAG-S53P4 seems to have no impact on the yield stress limit. The
extended allografts withstand the compaction equally good which makes it a valid bone substitute in total hip replacement. An in
vivo loaded study is needed before clinical use can be recommended. © 2015 Orthopaedic Research Society. Published by Wiley
Periodicals, Inc. J Orthop Res
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Compacted bone allografts are used to fill and recon-
struct bone defects in orthopaedic and trauma sur-
gery with good clinical long term results.1–3
Allografts are compacted to prevent early massive
subsidence of an implant.4,5 The initial stability of
the allografts also depends on the distribution of
grain sizes,3,5,6 as well as on the specific preparation
method.7–9 Different materials have been studied as
bone graft extenders to overcome shortages of mate-
rial from human donors.10–14
One such artificial substitute is bioglass.15 Bioactive
glasses are composed of SiO2, Na2O, CaO, and P2O5,
all of which naturally occur in the human body.16–18
The main advantage of bioglass is its bioactivity, while
its disadvantages include its mechanical weakness and
low fracture resistance. Bioglass S53P4 (BAG-S53P4)
bonds firmly to bone and promotes new bone formation
while naturally inhibiting bacterial growth.19 The
Young’s modulus of BAG-S53P4 is very close to that of
cortical bone.20,21 Lindfors et al. proved clinically that
the long-term performance is equivalent to that of
autogenic bone.19 It can be also used as a carrier
material for antibiotics.22
BAG-S53P4 has similar mechanical properties as
cortical bone tissue and could, therefore, be used as a
bone graft extender in case only limited bone material
is available.
The aim of this study was to evaluate the mechani-
cal effects of adding BAG-S53P4 to chemically treated
allografts with controlled grain size distribution.
METHODS
Femoral heads were donated by patients who underwent
total hip replacement surgery and gave their consent previ-
ously. The donated material was fresh-frozen at 80 ˚C and
stored at 20 ˚C. Cortical and cartilage tissues were removed
and the femoral heads were reduced to fragments smaller
than 10mm in diameter using a bone mill (Noviomagus,
coarse milling drum, Spierings Medische Techniek BV,
Nijmegen, The Netherlands) under sterile conditions.6,23
Allografts were washed chemically, dried for 4 days at 37 ˚C
and carefully mixed to minimize any patient-specific bone
characteristics.24 The allograft material was sieved (calibrat-
ed sieves; pore diameter between 0.063 and 16mm; Shaker
Amplitude 10mm with 1h application time; Haver and
Boecker, Oelde, Germany) and divided into two groups of 30
samples each:
 Allografts with BAG-S53P4 (BonAlive1 Biomateri-
als Ltd, Turku, Finnland) (BG)
 Control Group (CG)
In the BG group, particles smaller than 4mm were
substituted with BAG-S53P4, which is commercially avail-
able in three different grain sizes. The separated allograft
material was reassembled according to the particle size
composition specified in Table 1. Each sample was then
carefully mixed and the weight recorded. All samples under-
went a uniaxial compression test before and after being
compacted with a dropped weight apparatus in a compaction
chamber with an inner diameter of 40mm and a resulting
volume of 213.5 cm3. The allograft material was compacted
by dropping a weight of 1450 g 10 times from a height of
180mm onto the allograft material.
The allograft material was initially loaded by a consolida-
tion stress of 4 kPa in the vertical direction inducing an
initial density d1. With an electromechanical material testing
device (Zwicki-Line Z 2.5, maximal load 2.5 kN, 320 kHz
sample rate, accuracy 0.04N and 2mm, Zwick GmbH &
Co. KG, Ulm, Germany), the samples were loaded with an
increasing vertical stress at a constant compression velocity
of 2mm/min. A punch with a diameter of 15mm was used,
the preload was set to 5N, and the data sample rate was
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50Hz. The yield limit YL, as well as the density at the yield
limit dYL, was determined at the failure point of the material
(Fig. 1).
The coefficient of flowability (ffc) was calculated by
dividing the unconfined yield strength, YL, by the consolida-
tion stress. The coefficient of flowability provides a numerical
classification of the interlocking mechanism between par-
ticles with a flowablity below 1 being classified as not flowing
according to Jenike et al.25
The force displacement graphs measured by the electro-
mechanical testing machine were analyzed in OriginPro8.5
(Origin Lab Corporation, Northampton, Massachusetts). A
peak detection algorithm was used to determine the uncon-
fined yield limit. The trend of the measured curves was
eliminated by subtracting an exponential baseline. The
baseline was calculated over 50 anchor points, which were
determined after applying a smoothed 2nd polynomial order
function (Savitzky Golay smoothing method with window
size 10 and a threshold of 0.05). The peaks were then
extracted by searching for the positive local maxima over 100
points after applying a smoothing window-sized 50 measure-
ment points. The bulk density dYL at the failure point was
determined by considering the sample height at the instance
when material failure occurred.
The sample size of N¼ 52 resulted from a power analysis
performed for a two-tailed independent samples T-Test a
priori with an expected effect size of d¼ 0.8 (GPower 3.1.2,
Universit€at Kiel, Germany, a¼ 0.05, power¼ 0.80, number of
groups¼ 2).
The two-tailed T-Test for dependent samples was used to
compare the results before and after compaction within each
group. The two-tailed T-Test for independent samples was
used to compare BG and CG. All statistical calculations were
conducted with SPSS v.20 (IBM, Chicago, Illinois). A p-value
of <0.05 was considered statistically significant.
RESULTS
Adding BAG-S53P4 to the chemically treated allog-
rafts with controlled grain size distribution did not
affect the yield limit after compaction (Fig. 2). No
statistically significant difference regarding the yield
limit could be found between CG and BG after
compaction (p¼0.432).
Before compaction, a statistically significant in-
crease was observed for BG compared to CG for the
initial density (p<0.001), the density at the yield limit
(p<0.001), at the yield limit itself (p<0.001), and for
the flowability coefficient (p< 0.001) (Table 2). After
compaction, BG showed a statistically significant
higher initial density d1 (p<0.001), a higher density
at the yield limit dYL (p< 0.001), and a lower flowabil-
tiy coefficient ffc (p¼0.020) when compared to CG
(Table 3). The mean weight of the samples in BG was
8.030.03 g, while in CG, the samples had a weight of
Table 1. Grain Size Distributions for the Two Groups
are Reported
Group Material
Particle
Size (mm)
Quantity of Particles
(%) in Weight
BG Bone graft
material
>4 63.50
2.00–3.15 10.75
BonAlive1
BAG-S53P4
1.00–2.00 7.50
0.50–0.80 18.25
CG Bone graft
material
>4 63.50
2–4 10.75
1–2 7.50
<1 18.25
Figure 1. An example of the force and distance
variations while carrying out an uniaxial compres-
sion test. In Phase I, the punch is lowered into the
consolidated allografts. In Phase II, a significant
peak indicates the YL and the corresponding dYL
of the material under a compressive load. The
load is now bigger than the cohesive forces and
first fragments of the consolidated bone mass are
getting pulled out of the sample (circle). In Phase
III, more and more fragments are getting pulled
out (circle) and the bone mass is successive
destroyed by the compressive force. In Phase IV,
finally the sample was completely disintegrated
and the measured compressive force rises as some
bone fragments are blocked under the punch.
2 DAVID ET AL.
JOURNAL OF ORTHOPAEDIC RESEARCH MONTH 2015
8.01 0.01 g. There was no statistical significant dif-
ference in weight for the two groups (p¼0.269).
The coefficient of flowability was <1 for both groups
before compaction which can be classified as not
flowing (Fig. 3) according to Jenike et al.25 The
flowability coefficient decreased in both groups by a
factor of 10 after compaction. BG had the smallest
value of flowability, while CG had the highest value
before and after compaction.
Pair-wise comparisons within each group for the
values before and after compaction with the fall
hammer apparatus returned statistically significant
differences (p<0.001) for all parameters (initial densi-
ty d1, the density at the yield limit dYL, the yield limit
YL, and flowability coefficient ffc). In both groups,
compaction increased the initial density by 33% after
compaction (p< 0.001 for BG and CG), while the
density at the yield limit increased by 42% for CG
(p< 0.001) and 39% for BG (p< 0.001) (Fig. 4). The
yield limit YL showed an increase of approximately
96% in CG (p<0.001) and 93% in BG (p<0.001),
while the flowability coefficient decreased by approxi-
mately 95% for CG and 94% for BG, which confirms
the importance of impacting bone chips used for load
bearing applications like in hip arthroplasty (Fig. 5).
DISCUSSION
In BG, bone chips smaller than 4mm were substituted
with BAG-S53P4. The initial density as well as the
density at the yield limit was statistically significant
higher for BG when compared to CG. The difference of
the initial density before and after compaction was
equal for CG, which means that the volume reduction
was similar. Therefore, BAG-S53P4 showed a similar
resistance to the compression force of the fall hammer
apparatus. The density at the yield limit was statisti-
cally significant higher for BG than CG, still both
groups had the same grade of compaction of approxi-
mately 40%.
The higher initial density as well as the higher
density at the yield limit before and after compaction
of BG can be explained by the adding of smaller BAG-
S53P4 particles (>3.15) equally in weight as the
allografts (Table 1). The allografts in CG contained
also particles between 3.15–4mm. In BG, a tighter
“packaging” was obtained filling out spaces between
particles.
BAG-S53P4 has similar mechanical properties as
cortical bone tissue.20,21 Allografts, however, consist
mainly from spongious tissue. We would have expected
Figure 2. Comparison of the yield limit before and after a
standardized compaction for the two groups under evaluation.
Table 2. Comparison of Mean and Standard Deviation
of the Yield Limit (YL), Flowability Coefficient (ffc),
Initial Density d1, and Density at the Yield Limit dYL for
the Uncompacted Samples
CG BG p-Value
YL (MPa) 0.013 (0.009) 0.023 (0.012) p < 0.001
ffc 3.0 (1.6) 1.6 (1.1) p < 0.001
d1 (g/cm
3) 0.424 (0.052) 0.554 (0.050) p < 0.001
dYL (g/cm
3) 0.462 (0.061) 0.595 (0.062) p < 0.001
Figure 3. Comparison of the flowability coefficient before and
after a standardized compaction for the two groups under
evaluation.
Table 3. Comparison of Mean and Standard Deviation
of the Yield Limit (YL), Flowability Coefficient (ffc),
Initial Density d1, and Density at the Yield Limit dYL for
the Compacted Samples
CG BG p-Value
YL (MPa) 0.308 (0.163) 0.339 (0.140) p ¼ 0.432
ffc 0.13 (0.08) 0.10 (0.04) p ¼ 0.020
d1 (g/cm
3) 0.639 (0.081) 0.830 (0.078) p < 0.001
dYL (g/cm
3) 0.801 (0.308) 0.986 (0.084) p < 0.001
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a higher yield stress limit for BG compared to CG after
compaction. As no significant difference was found
between the two groups before and after compaction, it
proves that BAG-S53P4 has a similar mechanical
behavior under loading conditions as allograft despite
it mainly consist of spongiosa. Also, the amount of how
much the yield stress limit improved before and after
compaction was similar in both groups. It is, therefore,
not possible to draw any conclusions as to which group
shows a more favorable outcome regarding mechanical
stability.
The coefficient of flowability before compaction was
lower in BG than and in CG with CG displaying twice
the value of BG. After compaction, the flowability of
both groups was reduced by a factor of 10, with CG
having a higher flowabilty than BG. In CG, a much
larger reduction was observed. This indicates that the
BAG-S53P4 enhances the cohesion between the allo-
graft particles. After applying a compaction force, the
interlocking mechanism is not as evident anymore. On
the other hand, the allograft mixed with BAG-S53P4
had the highest densities in all cases compared to CG.
This could be due to the tight packaging of the
material reducing the flowability of the graft and the
resulting increased interlocking between the particles.
A limitation of the study is that the bone quality
was not measured in a densitometry analysis; howev-
er, only non-osteoporotic patients were selected for
bone tissue donation.
In BG, bone chips smaller than 4mm were substi-
tuted with BAG-S53P4 particles smaller than
3.15mm, which may have influenced the compaction
behavior and density measurements. The mechanical
results are applicable to cleaned dry bones and dry
BAG-S53P4. Mechanical properties will change when
the materials come in contact with liquids. As the dry
bone material and the BAG-S53P4 were very brittle, a
high standard deviation was observed in the yield
limit during mechanical testing. Further studies
should determine the quantity of liquids necessary to
achieve a satisfying result regarding the primary
stability.
Achieving a high density may not be the major goal
for the bone remodeling process as it may actually
obstruct new osteocytes from growing into the allo-
graft material.26 The influence of the density on the
bone remodeling process should be evaluated in fur-
ther studies to come for better conclusions on the bone
impaction technique. Also, the bone remodeling pro-
cess of cleaned, well graded allograft mixed with BAG-
S53P4 should be evaluated in terms of osteoconductiv-
ity and osteointegration.
We believe that using allografts in bone stock
reconstruction is a valid and proven method specifical-
ly beneficial for younger patients who are at risk of
facing another revision during their life.27–29 In 18% of
all hip revision cases performed in our institution, we
used allografts that have the potential to recreate
bone. Shortages in providing enough allografts in
specific gradation can be avoided using alternative
bone graft additives.30,31
In conclusion, the BAG-S53P4 extended allografts
withstand the compaction equally good as the allograft
alone, as no statically significant difference was found
for the yield stress limit. Many of the aspects dis-
cussed indicate that the BAG-S53P4 is ready to be
tested in an experimental animal model as a allograft
extender in vivo.
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